Mariana Feliciano, currently conducting her master’s thesis at NOVA Medical School, was awarded the Best Poster prize at the 4th Hospital da Luz Research Congress for her work in the field of cutaneous melanoma.
The research, carried out at the Membrane Trafficking in Disease Laboratory under the supervision of Professor Duarte Barral, aims to identify compounds that can reduce the progression of cutaneous melanoma. The focus is on inhibiting lysosome exocytosis - a cellular process that facilitates the migration and invasion of tumor cells, contributing to metastasis formation.
The study, titled "Targeting lysosome exocytosis to impair cutaneous melanoma progression", also seeks to understand how these compounds affect tumor cell behavior, paving the way for new therapeutic approaches.
The Hospital da Luz Research Congress promotes clinical-based research, encouraging the connection between fundamental science and medical practice, with a special focus on areas such as precision medicine, early diagnosis, artificial intelligence, and outcomes-based research.
This recognition highlights the role of translational research developed at NOVA Medical School, particularly in the development of new therapeutic strategies to fight skin cancer.